JUL 29, 2019 12:12 PM PDT

Compound Found in Wine May Treat Anxiety

WRITTEN BY: Nouran Amin

A study published in the journal Neuropharmacology claims that a compound found in red wine could be used as therapeutic for treating anxiety and depression disorders. The compound, called resveratrol, was seen too be involved in anti-stress effects by blocking the expression of an enzyme implicate din stress control of the brain. The study brings new light to how resveratrol is implicated in neurological processes and lays the ground work for future novel antidepressants that re safe and effective.

"Resveratrol may be an effective alternative to drugs for treating patients suffering from depression and anxiety disorders," says Ying Xu, MD, PhD, co-lead author and research associate professor in the UB School of Pharmacy and Pharmaceutical Sciences.

Resveratrol is plant-based and found in the skin and seeds of grapes and berries. Resveratrol has been known to be linked to multiple health benefits including neuroprotection. Recently, research has identified resveratrol’s main mechanism of action by targeting an enzyme known as phosphodiesterase 4 (PDE4)—which is influenced by the stress hormone corticosterone that regulates stress levels. When resveratrol targets PDE4 through inhibiting its actions, it brings antidepressant effects.

“These unknown physiological relationships make drug therapy complex. Current antidepressants instead focus on serotonin or noradrenaline function in the brain, but only one-third of patients with depression enter full remission in response to these medications,” says Xu.

Corticosterone induces excessive amounts of PDE4 in stressed mice and results in depression and anxiety-like behavior. PDE4 is known to reduce cyclic adenosine monophosphate -- a messenger molecule involved in signaling cellular physiological changes such as cell division, change, migration and death. These changes lead to physical alterations in the brain that such disorders begin to develop.

Source: Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
MAR 20, 2021
Drug Discovery & Development
Weekly Insulin for Type 2 Diabetes Proved Effective
MAR 20, 2021
Weekly Insulin for Type 2 Diabetes Proved Effective
A study found that a new once-weekly basal insulin injection holds similar efficacy, safety and lower rate of low blood ...
APR 02, 2021
Drug Discovery & Development
Anti-Parasitic Medication Could Be Therapy for COVID19
APR 02, 2021
Anti-Parasitic Medication Could Be Therapy for COVID19
What are tropical and neglected diseases? Chronic infections that plague developing nations with often little financial ...
APR 07, 2021
Drug Discovery & Development
Therapeutics Enhance The Body's Natural Killers
APR 07, 2021
Therapeutics Enhance The Body's Natural Killers
Most people who have been prescribed pain killers are familiar with fentanyl, oxycodone, and morphine. These substances ...
MAY 12, 2021
Cardiology
Reversing the Heart Damage Seen in Marfan Syndrome
MAY 12, 2021
Reversing the Heart Damage Seen in Marfan Syndrome
Marfan syndrome is a genetic disorder that disrupts the connective tissues that anchor and link the body's organs, affec ...
MAY 13, 2021
Health & Medicine
New Peptide Allows Cannabis to Fight Pain With Fewer Side Effects
MAY 13, 2021
New Peptide Allows Cannabis to Fight Pain With Fewer Side Effects
THC-rich cannabis is well known to bring relief for some chronic pain sufferers. But the downside, off putting for many ...
JUN 17, 2021
Drug Discovery & Development
FDA Approval of First New Alzheimer's Drug in Two Decades Sparks Controversy
JUN 17, 2021
FDA Approval of First New Alzheimer's Drug in Two Decades Sparks Controversy
The FDA recently approved a new drug known as Adulhelm, or aducanumab, to treat Alzheimer’s disease. The first new ...
Loading Comments...